Therapeutics (TGTX) 2025 Earnings Outlook for Investors
TG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
Discover credit cards that provide cash rewards without annual fees. Make your spending count!
26,108 articlesTG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
Snap is playing a high-stakes game. This article breaks down snap’s specs gamble, what it would take for AR hardware ...
Wingstop has flirted with 3,000 locations, but the real test for investors is what happens next. This article examine...
Analysts sometimes cut targets right before a big earnings release. This piece explains why that timing can mislead i...
Datadog stock has slid significantly from its 52-week peak, drawing bargain hunters. This deep dive explains whether ...
As Boyd Gaming nears its July 23 earnings, traders are weighing a potential 17.2% upside fueled by a disciplined buyb...
Choosing to claim Social Security at 62 is a turning point in retirement planning. This guide explains how that decis...
Lineage and Rexford Industrial Realty offer starkly different paths in industrial real estate. This guide breaks down...
The quantum computing sector has faced a pullback, but not every hire is a misfire. This article breaks down the rece...
This week brought a sharp move in Poet Technologies shares as a dilutive financing announcement rattled investors. Le...
Lemonade has chased rapid growth, but the real investment signal is in its loss ratio. This article explains why lemo...
In the first half of 2026, here's plug power stock surged 37.6%, signaling a renewed optimism around hydrogen fuels a...